WHO ICTRP trial
A prospective, randomized, masked and controlled trial of intravitreal…
EUCTR2008-006265-93-SE · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2008-006265-93-SE |
|---|---|
| Public title | A prospective, randomized, masked and controlled trial of intravitreal bevacizumab (Avastin®) for central retinal vein occlusion (CRVO). |
| Scientific title | A prospective, randomized, masked and controlled trial of intravitreal bevacizumab (Avastin®) for central retinal vein occlusion (CRVO). |
| Primary sponsor | St Eriks Eye Hospital |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Sweden |
| Conditions | Central retinal vein occlusion (CRVO) is a sight-threatening ocular condition without efficient treatment. |
| Interventions | Trade Name: Avastin ® Product Name: Avastin® Pharmaceutical Form: Injection* INN or Proposed INN: Bevacizumab Other descriptive name: BEVACIZUMABUM |
| Registration date | Oct 23, 2008 |
| Target size | 60 |
| Secondary IDs | AVO1 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: